Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
Raquel Guiomar, Ausenda Machado(National Institute of Health Dr. Ricardo Jorge), Rita Matos(Universidade do Porto), Anabela Santos Silva(National Institute of Health Dr. Ricardo Jorge), Ana Paula Rodrigues(Microsoft (Brazil)), J. M. Aguiar, Aryse Melo(National Institute of Health Dr. Ricardo Jorge), Carla Roque(National Institute of Health Dr. Ricardo Jorge), Ana João Santos, Fátima Graça(National Institute of Health Dr. Ricardo Jorge), Inês Costa, António Silva Graça(National Institute of Health Dr. Ricardo Jorge), Carla Nunes(National Institute of Health Dr. Ricardo Jorge), Irina Kislaya(German Center for Infection Research)
Cited by 18
Related Papers
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Stress Increases Vulnerability to Inflammation in the Rat Prefrontal Cortex
|Journal of Neuroscience|2006|212